Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 1, 2008, Pages 33-39

  Lang, Peter ^a   Mueller, Ingo ^a   Greil, Johann ^b   Bader, Peter ^c   Schumm, Michael ^a   Pfeiffer, Matthias ^a   Hoelle, Walter ^a   Klingebiel, Thomas ^c   Heinzelmann, Frank ^g   Belka, Claus ^g   Schlegel, Paul G ^d   Kremens, Bernhard ^e   Woessmann, Wilhelm ^f   Handgretinger, Rupert ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

^g UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Haploidentical; Pediatric; Rejection; Stem cells; Transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CD19 ANTIGEN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; MELPHALAN; OKT 3; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CAUSE OF DEATH; CD34 SELECTION; CHILD; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DONOR; DRUG TOLERABILITY; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; HUMAN CELL; INFECTION COMPLICATION; IRRADIATION; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; RETRANSPLANTATION; SALVAGE THERAPY; T CELL DEPLETION; THROMBOCYTE;

ADOLESCENT; ADULT; CAUSE OF DEATH; CELL COUNT; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; GRAFT REJECTION; GRAFT SURVIVAL; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; REOPERATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 36549065160     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.06.027     Document Type: Article

References (28)

1. Martin P.J. Overview of marrow transplantation immunology. In: Thomas E.D., Blume K.G., and Forman S.J. (Eds). Hematopoietic Stem Cell Transplantation (1999), Blackwell Science, Oxford 19-27
2. Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant. 29 (2002) 545-552
3. Quinones R.R. Hematopoietic engraftment and graft failure after bone marrow transplantation. Am. J. Pediatr. Hematol. Oncol. 15 (1993) 3-17
4. Johnston R.E., et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br. J. Haematol. 105 (1999) 1041-1043
5. Steffens H.P., Podlech J., Kurz S., Angele P., Dreis D., and Reddehase M.J. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J. Virol. 72 (1998) 5006-5015
6. Storb R., Prentice R.L., and Thomas E.D. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N. Engl. J. Med. 296 (1977) 61-66
7. Martin P.J., Akatsuka Y., Hahne M., and Sale G. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 92 (1998) 2177-2181
8. Westerhuis G., Maas W.G., Willemze R., Toes R.E., and Fibbe W.E. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 106 (2005) 2215-2220
9. Bordignon C., et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood 74 (1989) 2237-2243
10. Fleischhauer K., Kernan N.A., O'Reilly R.J., Dupont B., and Yang S.Y. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N. Engl. J. Med. 323 (1990) 1818-1822
11. *0901. Blood 98 (2001) 1122-1126
12. Anasetti C., et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N. Engl. J. Med. 320 (1989) 197-204
13. Martin P.J., et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66 (1985) 664-672
14. Grandage VL., et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant. 21 (1998) 687-690
15. Guardiola P., et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br. J. Haematol. 111 (2000) 292-302
16. Remberger M., et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant. 22 (1998) 73-78
17. Stucki A., Leisenring W., Sandmaier B.M., Sanders J., Anasetti C., and Storb R. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis). Blood 92 (1998) 2742-2749
18. Bader P., Holle W., Klingebiel T., Handgretinger R., Niethammer D., and Beck J. Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. Anticancer Res. 16 (1996) 1759-1763
19. Schumm M., et al. Flow cytometry with anti HLA antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplant 39 (2007) 767-773
20. Lang P., et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin. Padiatr. 217 (2005) 334-338
21. Schumm M., et al. Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations. Cytotherapy 8 (2006) 465-472
22. Schlegel P.G., et al. OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. Br. J. Haematol. 111 (2000) 668-673
23. Shah A.J., et al. Second hematopoietic stem cell transplantation in pediatric patients: overall survival and long-term follow-up. Biol. Blood Marrow Transplant. 8 (2002) 221-228
24. Woodard P., et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J. Pediatr. Hematol. Oncol. 25 (2003) 955-959
25. Zecca M., et al. Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children. Br. J. Haematol. 92 (1996) 432-434
26. Cho S.G., et al. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation. Exp. Hematol. 32 (2004) 1246-1254
27. Dey B.R., et al. Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br. J. Haematol. 128 (2005) 351-359
28. Rubio M.T., Kim Y.M., Sachs T., Mapara M., Zhao G., and Sykes M. Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma. Blood 102 (2003) 2300-2307